Overview
Inger De Ridder practices practicing medicine in Maastricht, Netherlands.
De Ridder is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Stroke, Subarachnoid Hemorrhage, and Thrombectomy.
They are actively involved in clinical research, co-authoring 34 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Inger R. De Ridder
Is Inger R. De Ridder a top-rated expert for Thrombectomy?
MediFind is an objective health platform that identifies experts based on real-world data. Inger R. De Ridder is classified as an Advanced expert for Thrombectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Inger R. De Ridder participate in research or clinical trials?
Yes. Inger R. De Ridder has published 34 articles and abstracts on conditions like Thrombectomy. You can view a list of Inger R. De Ridder's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- StrokeDe Ridder isAdvanced. Learn about Stroke.
- ThrombectomyDe Ridder isAdvanced. Learn about Thrombectomy.
- Experienced
- Subarachnoid HemorrhageDe Ridder isExperienced. Learn about Subarachnoid Hemorrhage.